尽管新冠肺炎的病例持续增多,但美国感染新冠病毒德尔塔变种的病例增长尚未达到峰值。根据美国疾病控制与预防中心(Centers for Disease Control)的最新预测,在8月8日至14日期间收集的患者样本中,有多达98.8%的病例感染了德尔塔变种病毒,接种疫苗率不高的地区明显受到德尔塔变种病毒的影响。据《纽约时报》(New York Times)报道,截至8月17日,7天平均每天新增新冠肺炎病例139872例,接近今年2月以来的最高水平。
最初的实验数据表明:不同于以前的新冠病毒菌株,感染德尔塔变种病毒的征兆和症状可能有一些微妙的变化。同时,德尔塔变种病毒可能对儿童产生不同或更严重的影响,这是我们在这次疫情期间中忽略的关键问题。这个关键问题也反映出全国大部分地区学校的疫情防控的情况。
美国儿科学会(American Academy of Pediatrics)报告说,新的儿童冠状病毒感染正在增长。在7月的第一周内,此类案件有12000起;然后在8月的第一周增加96000人;8月5日至12日期间,儿童中有121000多例新冠病毒感染,占该周报告的所有病例的18%。其他健康儿童的住院率也在上升,这种疾病可能会在感染变异病毒的人身上引起更严重的症状,尽管儿科医生告诉《华盛顿邮报》(Washington Post),这些年轻患者大部分是12岁以下的人,他们还没有资格接种疫苗,或者有资格的年轻人因为其他原因推迟了注射。
那么,哪些症状可能在感染德尔塔变种病毒的美国人,尤其是在年轻人群体中,较为普遍呢?鉴于新冠病毒对不同患者群体的身体产生广泛影响,患者出现的症状因人而异。一些相对常见的症状包括味觉或嗅觉丧失、疲劳、头痛、发烧、呼吸困难、肌肉疼痛、恶心、腹泻和呕吐等胃肠道问题以及皮疹等。新冠病毒症状研究(COVID Symptom Study)等项目允许患者将自己的症状输入信息化数据库,该数据库可以跟踪哪些症状在哪些地区呈上升趋势以及监测新菌株对拥有“很长潜伏期”的人存在何种影响,这种人可能一开始没有症状,但在感染一个月或更长时间后出现症状。
一些相关研究以及权威医院的相关传言表明,对于德尔塔变异病毒,大多数症状发生在你的头部和鼻腔区域。肠道问题和皮肤问题,例如青春痘在感染德尔塔变种病毒的成人和儿童中都不那么普遍。许多相关病例没有出现感染普通型新冠病毒后的一些典型症状。
“咳嗽和嗅觉丧失似乎不太常见。根据最近英国的一项调查显示,90%德尔塔变种病毒病例出现头痛、喉咙痛、流鼻涕和发烧的症状都比较普遍。”耶鲁医学院(Yale Medicine)的儿科传染病专家和疫苗学家因吉•伊迪利姆博士说。
诺斯威尔医疗集团(Northwell Health)旗下亨廷顿医院(Huntington Hospital)的首席医疗官、儿科主任迈克尔•格罗索等其他人,基于自己病人的病史,对这一观点表示赞同。同时注意到儿童和成人之间的症状有细微差异。格罗索告诉Healthline,比如,虽然与普通新冠病毒相比,感染德尔塔变异病毒的患者不常咳嗽,但它在儿童中可能更常见,而携带德尔塔变异病毒的成年人可能会流鼻涕,但年轻的患者可能不会。根据他的经验,感染德尔塔变种病毒的儿童最常见的症状是发烧和咳嗽,“出现上呼吸道症状、胃肠道症状,皮疹等症状比较少见。”
虽然德尔塔变异病毒相关的住院病例和死亡病例数量在上升,而且变成一个恶劣的公共卫生问题,但与疫情高峰时期相比数量仍然相对较少,毕竟当时每天有超过4000病例死亡。这个数字现在更接近每日450至750例死亡,这取决于你看到的是哪一天的数据。
不过年轻人(尤其是未接种疫苗的人)感染德尔塔变异病毒后的严重症状让重症监护室的医生感到担忧,因为其他新冠病毒毒株可能完全没有被其他健康或没有潜在疾病的患者察觉到。但对这种类型的患者来说,情况可能并非如此,人们担心年轻人和儿童患者的身体难以承受长时间的伤害,他们必须住院治疗来恢复健康。
美国可能仍然处于德尔塔变异病毒评估的早期阶段,只有对相关病例开展长期有效的监测,才能帮助专家收集关于不同病毒变体如何影响不同人群的数据。与此同时,与新冠病毒的长期斗争可能会进一步鼓励联邦官员,向所有年龄段人群开放疫苗接种,并尽快扩大加强剂的接种范围,以便全面接种疫苗。(财富中文网)
编译:於欣
尽管新冠肺炎的病例持续增多,但美国感染新冠病毒德尔塔变种的病例增长尚未达到峰值。根据美国疾病控制与预防中心(Centers for Disease Control)的最新预测,在8月8日至14日期间收集的患者样本中,有多达98.8%的病例感染了德尔塔变种病毒,接种疫苗率不高的地区明显受到德尔塔变种病毒的影响。据《纽约时报》(New York Times)报道,截至8月17日,7天平均每天新增新冠肺炎病例139872例,接近今年2月以来的最高水平。
最初的实验数据表明:不同于以前的新冠病毒菌株,感染德尔塔变种病毒的征兆和症状可能有一些微妙的变化。同时,德尔塔变种病毒可能对儿童产生不同或更严重的影响,这是我们在这次疫情期间中忽略的关键问题。这个关键问题也反映出全国大部分地区学校的疫情防控的情况。
美国儿科学会(American Academy of Pediatrics)报告说,新的儿童冠状病毒感染正在增长。在7月的第一周内,此类案件有12000起;然后在8月的第一周增加96000人;8月5日至12日期间,儿童中有121000多例新冠病毒感染,占该周报告的所有病例的18%。其他健康儿童的住院率也在上升,这种疾病可能会在感染变异病毒的人身上引起更严重的症状,尽管儿科医生告诉《华盛顿邮报》(Washington Post),这些年轻患者大部分是12岁以下的人,他们还没有资格接种疫苗,或者有资格的年轻人因为其他原因推迟了注射。
那么,哪些症状可能在感染德尔塔变种病毒的美国人,尤其是在年轻人群体中,较为普遍呢?鉴于新冠病毒对不同患者群体的身体产生广泛影响,患者出现的症状因人而异。一些相对常见的症状包括味觉或嗅觉丧失、疲劳、头痛、发烧、呼吸困难、肌肉疼痛、恶心、腹泻和呕吐等胃肠道问题以及皮疹等。新冠病毒症状研究(COVID Symptom Study)等项目允许患者将自己的症状输入信息化数据库,该数据库可以跟踪哪些症状在哪些地区呈上升趋势以及监测新菌株对拥有“很长潜伏期”的人存在何种影响,这种人可能一开始没有症状,但在感染一个月或更长时间后出现症状。
一些相关研究以及权威医院的相关传言表明,对于德尔塔变异病毒,大多数症状发生在你的头部和鼻腔区域。肠道问题和皮肤问题,例如青春痘在感染德尔塔变种病毒的成人和儿童中都不那么普遍。许多相关病例没有出现感染普通型新冠病毒后的一些典型症状。
“咳嗽和嗅觉丧失似乎不太常见。根据最近英国的一项调查显示,90%德尔塔变种病毒病例出现头痛、喉咙痛、流鼻涕和发烧的症状都比较普遍。”耶鲁医学院(Yale Medicine)的儿科传染病专家和疫苗学家因吉•伊迪利姆博士说。
诺斯威尔医疗集团(Northwell Health)旗下亨廷顿医院(Huntington Hospital)的首席医疗官、儿科主任迈克尔•格罗索等其他人,基于自己病人的病史,对这一观点表示赞同。同时注意到儿童和成人之间的症状有细微差异。格罗索告诉Healthline,比如,虽然与普通新冠病毒相比,感染德尔塔变异病毒的患者不常咳嗽,但它在儿童中可能更常见,而携带德尔塔变异病毒的成年人可能会流鼻涕,但年轻的患者可能不会。根据他的经验,感染德尔塔变种病毒的儿童最常见的症状是发烧和咳嗽,“出现上呼吸道症状、胃肠道症状,皮疹等症状比较少见。”
虽然德尔塔变异病毒相关的住院病例和死亡病例数量在上升,而且变成一个恶劣的公共卫生问题,但与疫情高峰时期相比数量仍然相对较少,毕竟当时每天有超过4000病例死亡。这个数字现在更接近每日450至750例死亡,这取决于你看到的是哪一天的数据。
不过年轻人(尤其是未接种疫苗的人)感染德尔塔变异病毒后的严重症状让重症监护室的医生感到担忧,因为其他新冠病毒毒株可能完全没有被其他健康或没有潜在疾病的患者察觉到。但对这种类型的患者来说,情况可能并非如此,人们担心年轻人和儿童患者的身体难以承受长时间的伤害,他们必须住院治疗来恢复健康。
美国可能仍然处于德尔塔变异病毒评估的早期阶段,只有对相关病例开展长期有效的监测,才能帮助专家收集关于不同病毒变体如何影响不同人群的数据。与此同时,与新冠病毒的长期斗争可能会进一步鼓励联邦官员,向所有年龄段人群开放疫苗接种,并尽快扩大加强剂的接种范围,以便全面接种疫苗。(财富中文网)
编译:於欣
The COVID Delta variant surge has yet to peak in the U.S., as coronavirus infections continue their upward trajectory. The variant was present in as many as 98.8% of patient samples collected between Aug. 8 and Aug. 14, according to the latest available Centers for Disease Control (CDC) projections, with highly unvaccinated regions bearing the brunt of this wave. The seven-day average of new COVID cases was tracking at just over 139,872 per day as of Aug. 17, per the New York Times, nearing levels not seen since February.
Initial on-the-ground data suggests that the signs and symptoms of the Delta variant may differ from previous strains in subtle ways, and that Delta may also affect children in different and more serious ways than we have seen before in this pandemic—a key issue to monitor as in-person school resumes across much of the nation.
The American Academy of Pediatrics reports that new child COVID infections are ballooning. There were 12,000 such cases during the first week of July; then 96,000 over the first week of August; and more than 121,000 COVID infections in kids between Aug. 5 and 12, or 18% of all cases reported that week. Hospitalizations in otherwise healthy children are also on the rise, and the disease may cause more serious symptoms in those who contract the variant, although pediatric doctors tell the Washington Post that the bulk of these young patients are either those under the age of 12, who don't qualify for a vaccine yet, or eligible youth who have otherwise delayed getting a jab.
So which symptoms may be more prevalent among Americans with a Delta variant case, and specifically for younger people? Patient symptoms can vary widely, given the wide spectrum of COVID's effects on the body among different patient demographics. Some relatively common signs of COVID include loss of taste and/or smell, fatigue, headaches, fever, trouble breathing, muscle aches and pains, gastrointestinal troubles like nausea, diarrhea, and vomiting, or a skin rash, among others. Projects such as the COVID Symptom Study allow patients to enter their own symptoms into a digital database that can track which ones are on the rise in which regions, as well as monitoring what new strains mean for those who contract "long COVID," in which someone may be asymptomatic initially but then develop disease symptoms a month or more after infection.
Such studies and anecdotal evidence from major hospitals suggest that with the Delta variant, most symptoms occur in your head and nasal region. Gut problems and skin breakouts appear less prevalent in both adults and children with a Delta case. Many Delta cases also lack some classic symptoms of COVID.
“It seems like cough and loss of smell are less common. And headache, sore throat, runny nose, and fever are present based on the most recent surveys in the U.K., where more than 90% of the cases are due to the Delta strain,” according to Yale Medicine pediatric infectious diseases specialist and vaccinologist Dr. Inci Yildirim.
Others such as Dr. Michael Grosso, chief medical officer and chair of pediatrics at Northwell Health’s Huntington Hospital, largely concur based on their own patient experiences while noting subtle Delta symptom differences between kids and grownups. For instance, while cough may be less common generally among Delta variant patients compared with the original coronavirus, it may be more common among children, Grosso told Healthline, and while adults with the Delta variant may get a runny nose, a younger patient may not. In his experience, the most common symptoms in children who have the strain are fever and cough, "with nasal symptoms, gastrointestinal symptoms, and rash happening much less often."
The number of COVID-related hospitalizations and deaths due to the Delta variant, while on the rise and a clear public health concern, still remain relatively low compared with the height of the pandemic, when upwards of 4,000 people were dying every day. That number is now closer to 450 to 750 new daily deaths, depending on which day's data you're looking at.
But the relative severity of Delta variant symptoms in younger people, especially the unvaccinated, has ICU doctors concerned since other COVID strains may have gone entirely unnoticed by an otherwise healthy patient with no underlying conditions. That may not be the case for this variety, raising fears of lasting damage in young adults and child patients who have to be hospitalized and recuperate from their illness.
The U.S. may still be in the earlier days of its COVID Delta reckoning, and only aggressive patient monitoring over the long term will help experts glean more knowledge about how different coronavirus mutations affect different people. But an extended battle with this persistent pathogen may further encourage federal officials to open up COVID vaccines to all ages and expand the reach of booster doses for the fully vaccinated sooner rather than later.